A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other s
Posted: Fri Jun 08, 2018 8:33 am
A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).
https://meetinglibrary.asco.org/record/162020/abstract
https://meetinglibrary.asco.org/record/162020/abstract